Molecular
Quality Control Market by Product Type (Independent Control, Instrument
Specific Control (DNA Sequencing and NGS, PCR, and Others)), by Analyte (Single
Analyte, and Multi Analyte), by Application (Oncology, Genetic Testing,
Infectious Diseases, and Others), by End Users (Clinical Laboratories,
Hospitals and Clinics, Research and Academic Institutes, and Others), and by
Region (North America, Europe, Asia Pacific, Latin America, Middle East, and
Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2026
Molecular quality control mainly
used for monitoring the performance of in vitro nucleic acid testing procedures
for viral load assays, healthcare-associated infections (HAIs) including
bloodstream infections, urinary tract infections, pneumonia, and other
infections related to sexually transmitted diseases. Main focus of molecular
quality control is to test molecular diagnostic products, identify defects and
report them to management authorities.
Molecular Quality Control Market
Drivers
Expansion of business by key
players is expected to boost the molecular quality control market growth. For
instance, in July 2016, Bio-Rad Laboratories, Inc. announced its expansion into
the molecular diagnostic testing market with the launch of its new quality
control system Amplichek Quality Control. This quality control is used for
molecular diagnostic testing of infectious diseases.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2674
Furthermore, in April 2019,
Bruker announced the expansion for its MALDI Biotyper, IR Biotyper and
Fluorocycler XT product lines. These products will be used for microbial
identification, infection control, and molecular diagnostics of infectious
diseases.
Moreover, increasing partnership
activities are expected to drive the molecular quality control market growth.
For instance, in February 2018, Randox Laboratories announced its strategic
partnership with Qnostics to enhance the market potential of its Qnostics
products.
Molecular Quality Control Market
Restraints
Inaccurate genetic tests are
expected to hinder growth of the molecular quality control market. For
instance, in August 2017, Invitae Corporation identified a quality control
issue with a hereditary cancer test, which provided false, negative results. This
hereditary cancer test is carried out on those patient who have a rare genetic
variant in the MSH2 gene which is associated with the Lynch syndrome.
Molecular Quality Control Market
Regional Analysis
On the basis of region, the
global molecular quality control market is segmented into North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/molecular-quality-control-market-2674
North America is expected to hold
a dominant position in the global molecular quality control market, owing to
increasing launches of new control panels by key players. For instance, in
December 2018, Microbiologics, Inc. launched two new panels, Group A
Streptococcus (GAS) and respiratory molecular assays, for quality control
processes. These two panels include convenient features such as multiplexed
pellets, swabs that mimic patient sample processing, and room temperature
storage.
Furthermore, Asia Pacific is also
projected to witness significant growth in the global molecular quality control
market, owing to increasing partnership activities by key players. In June
2016, Thermo Fisher Scientific Inc., announced its partnership with West China
Hospital of Sichuan University to enhance quality of pathological research and
diagnosis and to accelerate development of precise pathological diagnosis.
Key players operating in the,
global molecular quality control market include Seracare Life Sciences, Inc.,
Zeptometrix, Thermo Fisher Scientific, Abbott Laboratories, Maine Molecular
Quality Controls, Inc., Quidel, Qnostics, Bio-Rad Laboratories, Roche Diagnostics,
Microbiologics, Inc., and Theranostica.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2674
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to emerging
market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment